Increasing numbers of individuals in African countries have access to essential medicines, and the critical need for strong surveillance and adverse event reporting systems is evident. Though pharmacovigilance infrastructure is beginning to be deployed more widely in Africa, there is limited data on the actual performance from a systems perspective.
To address this critical gap, the Strengthening Pharmaceutical Systems (SPS) Program conducted a study of pharmacovigilance systems and performance in sub-Saharan Africa in 2011, led by individual focus country National Regulatory Authorities, with support from an interagency agreement between the U.S. Food and Drug Administration (FDA) and the U.S. Agency for International Development (USAID).
The 2012 Pharmacovigilance Meeting, which is being hosted by the Ministry of Health, Kenya; the Pharmacy and Poisons Board; the USAID-funded, MSH-led Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program; and the USAID-funded, MSH-led Health Commodities and Services Management (HCSM) Program will bring together partners from the African Regulatory Authorities, WHO, BMGF, EMA, CDC, FDA, USAID, and other key stakeholders to disseminate the study findings and facilitate a dialogue around common needs and opportunities.
The meeting includes a one-day launch of the study publication, Safety of Medicines in Sub-Saharan Africa: Assessment of Pharmacovigilance Systems and their Performance, followed by a two-day intensive workshop where countries will share their current practices and collectively identify operational tools and guidelines needed to implement pharmacovigilance activities with a systems perspective.
Simultaneous translation in French will be provided throughout the meeting.
We look forward to your attendance at this exciting event.
For any questions, please contact email@example.com.